New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
06:01 EDTNVAXNovavax price target raised to $9 from $7 at Piper Jaffray
Piper Jaffray raised its price target for Novavax shares to $9 and says the stock remains a top pick for 2014. Piper believes the company's RSV vaccine in development is a potential blockbuster and reiterates an Overweight rating in the stock.
News For NVAX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 20, 2014
09:21 EDTNVAXOn The Fly: Pre-market Movers
Subscribe for More Information
08:39 EDTNVAXNovavax granted FDA fast track designation to RSV F vaccine
Novavax announced that the FDA has granted Fast Track Designation to Novavax' RSV F-Protein nanoparticle vaccine candidate, or RSV F vaccine, for protection of infants via maternal immunization.
November 17, 2014
16:10 EDTNVAXNovavax initiates Phase 2 clinical trial of quadrivalent seasonal influenza VLP
Subscribe for More Information
November 14, 2014
17:14 EDTNVAXNovavax initiates phase 2 clinical trial of RSV vaccine in elderly subjects
Subscribe for More Information
November 10, 2014
08:53 EDTNVAXNovavax initiates Phase 1 clinical trial of RSV F vaccine
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use